Bridgeway Capital Management, LLC Co Diagnostics, Inc. Transaction History
Bridgeway Capital Management, LLC
- $4.76 Billion
- Q1 2024
A detailed history of Bridgeway Capital Management, LLC transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 272,900 shares of CODX stock, worth $365,686. This represents 0.01% of its overall portfolio holdings.
Number of Shares
272,900
Previous 272,900
-0.0%
Holding current value
$365,686
Previous $362,000
15.75%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding CODX
# of Institutions
46Shares Held
4.23MCall Options Held
22.9KPut Options Held
30.4K-
Vanguard Group Inc Valley Forge, PA1.78MShares$2.39 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny600KShares$804,5360.0% of portfolio
-
Black Rock Inc. New York, NY500KShares$670,0670.0% of portfolio
-
Geode Capital Management, LLC Boston, MA294KShares$394,5250.0% of portfolio
-
Kestra Advisory Services, LLC149KShares$199,5800.0% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $45.3M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...